American Academy of Allergy, Asthma & Immunology Annual Meeting 2026

Detailed Information

Meeting Date:

02/27/2026

Oral Abstract:
VITESSE Phase 3 Study: Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children 4 Through 7 Years of Age

View Presentation

Scroll to Top